|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.400 CNY | +2.41% |
|
+6.25% | -14.57% |
| Market Cap | 2.67B 393M 345M 320M 294M 556M 37.65B 567M 3.81B 1.49B 18.49B 1.48B 1.44B 63.85B | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 2.88B 425M 373M 346M 318M 601M 40.71B 613M 4.12B 1.62B 19.99B 1.6B 1.56B 69.04B | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
69.52% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.41% | ||
| 1 week | +6.25% | ||
| Current month | +14.48% | ||
| 1 month | +3.34% | ||
| 3 months | -29.31% | ||
| 6 months | -18.27% | ||
| Current year | -14.57% |
| 1 week | 3.07 |  | 3.46 |
| 1 month | 2.85 | | 3.46 |
| Current year | 2.85 | | 5.27 |
| 1 year | 2.85 | | 5.27 |
| 3 years | 2.76 | | 6.15 |
| 5 years | 2.76 | | 8.8 |
| 10 years | 2.76 | | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 2021-05-12 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 2024-09-05 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 2019-09-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 2009-01-21 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 2011-02-20 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 2019-01-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.41% | +6.25% | -17.27% | -34.87% | 384M | |
| -0.04% | -0.88% | +48.80% | +173.63% | 1,060B | |
| +0.33% | -0.26% | +64.93% | +62.87% | 619B | |
| -0.12% | -2.77% | +29.33% | +85.41% | 438B | |
| -1.75% | -0.33% | +28.33% | +23.58% | 333B | |
| +0.24% | -0.42% | +29.19% | +47.26% | 282B | |
| -1.75% | -10.57% | +18.27% | +22.07% | 267B | |
| +0.67% | +1.03% | -26.81% | -37.96% | 218B | |
| -0.83% | -1.54% | +21.46% | +58.47% | 196B | |
| +1.23% | +1.42% | +17.28% | +71.37% | 161B | |
| Average | +0.11% | -2.21% | +21.35% | +47.18% | 357.43B | |
| Weighted average by Cap. | -0.14% | -3.09% | +35.93% | +84.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.17B 321M 281M 260M 240M 453M 30.69B 462M 3.1B 1.22B 15.07B 1.2B 1.18B 52.05B | 1.86B 275M 241M 223M 205M 388M 26.3B 396M 2.66B 1.04B 12.91B 1.03B 1.01B 44.6B |
| Net income | -317M -46.78M -41.03M -38.01M -34.97M -66.14M -4.48B -67.43M -453M -178M -2.2B -176M -172M -7.59B | -330M -48.6M -42.63M -39.48M -36.33M -68.72M -4.65B -70.05M -471M -185M -2.28B -183M -179M -7.89B |
| Net Debt | 411M 60.6M 53.15M 49.23M 45.29M 85.67M 5.8B 87.34M 587M 230M 2.85B 228M 223M 9.84B | 217M 32.02M 28.08M 26.01M 23.93M 45.27M 3.06B 46.15M 310M 122M 1.51B 120M 118M 5.2B |
Employees
4,832
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-12 | CN¥3.400 | +2.41% | 36,638,170 |
| 26-07-10 | CN¥3.320 | +5.40% | 35,226,991 |
| 26-07-09 | CN¥3.150 | -0.32% | 13,205,327 |
| 26-07-08 | CN¥3.160 | +0.32% | 15,263,713 |
| 26-07-07 | CN¥3.150 | -4.26% | 18,555,800 |
- Stock Market
- Stocks
- 600594 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
